Related Experiment Video
Updated: Jul 2, 2026

The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
Comorbidity, socioeconomic status and multiple sclerosis
Objective:
Multiple sclerosis (MS) is associated with substantial morbidity. The impact of comorbidity on MS is unknown, but comorbidity may explain some of the unpredictable progression. Comorbidity is common in the general population, and is associated with adverse health outcomes. To begin understanding the impact of comorbidity on MS, we need to know the breadth, type, and frequencies of comorbidities among MS patients. Using the North American Research Committee on Multiple Sclerosis (NARCOMS) Registry, we aimed to describe comorbidities and their demographic predictors in MS.
Methods:
In October 2006, we queried NARCOMS participants regarding physical comorbidities. Of 16,141 participants meeting the inclusion criteria, 8983 (55.7%) responded.
Results:
Comorbidity was relatively common; if we considered conditions which are very likely to be accurately self-reported, then 3280 (36.7%) reported at least one physical comorbidity. The most frequently reported comorbidities were hypercholesterolemia (37%), hypertension (30%), and arthritis (16%). Associated with the risk of comorbidity were being male [females vs. males, odds ratio (OR) 0.77; 0.69-0.87]; age (age >60 years vs. age < or = 44 years, OR 5.91; 4.95-7.06); race (African Americans vs. Whites, OR 1.46; 1.06-2.03); and socioeconomic status (Income <$15,000 vs. Income >$100,000, OR 1.37; 1.10-1.70).
Conclusions:
Comorbidity is common in MS and similarly associated with socioeconomic status.
Insights
Comorbidity is common in multiple sclerosis (MS) patients, with hypercholesterolemia, hypertension, and arthritis being most frequent. Risk factors include older age, male sex, African American race, and lower socioeconomic status.
Area of Science:
- Neurology
- Epidemiology
- Public Health
Background:
- Multiple sclerosis (MS) is a debilitating neurological disease with significant morbidity.
- The influence of comorbid conditions on MS progression and outcomes remains largely unknown.
- Comorbidities are prevalent in the general population and linked to adverse health events.
Purpose of the Study:
- To investigate the prevalence, types, and demographic predictors of comorbidities in individuals with multiple sclerosis.
- To establish a baseline understanding of the comorbidity burden in the MS population.
Main Methods:
- Utilized data from the North American Research Committee on Multiple Sclerosis (NARCOMS) Registry.
- Surveyed 16,141 eligible participants about physical comorbidities, with 8,983 (55.7%) responding.
Main Results:
- 36.7% of respondents reported at least one physical comorbidity.
- Most common comorbidities included hypercholesterolemia (37%), hypertension (30%), and arthritis (16%).
- Increased comorbidity risk was associated with older age, male sex, African American race, and lower socioeconomic status.
Conclusions:
- Comorbidity is a common issue among individuals with multiple sclerosis.
- Socioeconomic status is a significant factor associated with comorbidity in MS patients.
Related Concept Videos
Multiple Sclerosis l: Introduction
Factors Affecting Illness
For instance, risk factors are connected to illness, disability,...
Psychological and Sociocultural Causes of Schizophrenia
Factors Influencing Drug Absorption: Disease States and Pharmacology
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Myasthenia Gravis ll: Pathophysiology
